7-135135071-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178563.4(AGBL3):āc.2573A>Gā(p.Lys858Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000271 in 1,551,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178563.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGBL3 | NM_178563.4 | c.2573A>G | p.Lys858Arg | missense_variant | 17/17 | ENST00000436302.6 | NP_848658.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGBL3 | ENST00000436302.6 | c.2573A>G | p.Lys858Arg | missense_variant | 17/17 | 2 | NM_178563.4 | ENSP00000388275 | P2 | |
CYREN | ENST00000459937.5 | n.356+33678T>C | intron_variant, non_coding_transcript_variant | 1 | ||||||
AGBL3 | ENST00000435976.6 | c.2111-12742A>G | intron_variant | 5 | ENSP00000401220 | A2 | ||||
CYREN | ENST00000464070.1 | n.187+12906T>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152098Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000195 AC: 3AN: 153536Hom.: 0 AF XY: 0.0000246 AC XY: 2AN XY: 81438
GnomAD4 exome AF: 0.0000286 AC: 40AN: 1399014Hom.: 0 Cov.: 31 AF XY: 0.0000319 AC XY: 22AN XY: 690020
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152098Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2024 | The c.2573A>G (p.K858R) alteration is located in exon 17 (coding exon 16) of the AGBL3 gene. This alteration results from a A to G substitution at nucleotide position 2573, causing the lysine (K) at amino acid position 858 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at